Innoviva Company Profile (NASDAQ:THRX)

About Innoviva

Innoviva logoInnoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Its portfolio focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol (FF/VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). It operates in providing capital return to stockholders by maximizing the potential value of its respiratory assets partnered with GSK segment. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of VI, a LABA and FF, an inhaled corticosteroid (FF/VI) delivered via the ELLIPTA dry powder inhaler. ANORO ELLIPTA is a dual bronchodilator consisting of UMEC, a long-acting muscarinic antagonist (LAMA) and VI, a LABA for the treatment of chronic obstructive pulmonary diseases (COPD).

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: THRX
  • CUSIP:
Key Metrics:
  • Previous Close: $9.81
  • 50 Day Moving Average: $9.81
  • 200 Day Moving Average: $11.67
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 32.70
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for Innoviva (NASDAQ:THRX) (?)
Ratings Breakdown: 1 Sell Rating
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: $7.00 (28.64% downside)

Analysts' Ratings History for Innoviva (NASDAQ:THRX)
Show:
DateFirmActionRatingPrice TargetDetails
5/2/2016Morgan StanleyReiterated RatingSell$7.00View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Innoviva (NASDAQ:THRX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Innoviva (NASDAQ:THRX)
Current Year EPS Consensus Estimate: $-0.19 EPS
Next Year EPS Consensus Estimate: $0.30 EPS

Dividends

Dividend History for Innoviva (NASDAQ:THRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Innoviva (NASDAQ:THRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Innoviva (NASDAQ:THRX)
DateHeadline
finance.yahoo.com logoTHRX : Summary for Theravance, Inc. - Yahoo Finance (NASDAQ:THRX)
ca.finance.yahoo.com - February 23 at 9:48 PM
feeds.reuters.com logoBRIEF-Innoviva says GSK announces launch of Anoro in France (NASDAQ:THRX)
feeds.reuters.com - January 30 at 4:46 PM
News IconHedge Funds Can’t Get Enough of Innoviva Inc (INVA) (NASDAQ:THRX)
feedproxy.google.com - December 7 at 10:24 PM
publicnow.com logoTheravance Biopharma, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update (NASDAQ:THRX)
www.publicnow.com - November 8 at 7:48 PM
publicnow.com logoTheravance Biopharma Announces Positive Results Including Biomarker Data from Phase 1 Multiple-Ascending Dose Study of TD-0714, an Inhibitor of Neprilysin (NEP) (NASDAQ:THRX)
www.publicnow.com - October 25 at 9:49 AM
publicnow.com logoTheravance Biopharma to Present New Data from Multiple Studies of VIBATIV(R) (telavancin), Including Ongoing TOUR(TM) Observational Patient Registry, at IDWeek 2016 (NASDAQ:THRX)
www.publicnow.com - October 18 at 10:15 AM
publicnow.com logoTheravance Biopharma Announces First Subject Dosed in Phase 1b Clinical Trial of TD-1473 in Patients With Moderate to Severe Ulcerative Colitis (NASDAQ:THRX)
www.publicnow.com - October 4 at 9:56 AM
publicnow.com logoTheravance Biopharma, Inc. Reports Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:THRX)
www.publicnow.com - August 8 at 8:00 PM
publicnow.com logoNew Data Analyses From Phase 3 ATTAIN Trials Support VIBATIV(R) (Telavancin) as a Treatment for Staphylococcus Aureus HABP/VABP, Including Cases Caused by MRSA (NASDAQ:THRX)
www.publicnow.com - May 16 at 8:32 AM
publicnow.com logoTheravance Biopharma to Present New Data Analyses From Phase 3 ATTAIN Trials of VIBATIV(R) (telavancin) in Treatment of HABP/VABP at American Thoracic Society 2016 International Conference (NASDAQ:THRX)
www.publicnow.com - May 11 at 8:52 AM
publicnow.com logoTheravance Biopharma, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update (NASDAQ:THRX)
www.publicnow.com - May 9 at 4:38 PM
publicnow.com logoTheravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin) (NASDAQ:THRX)
www.publicnow.com - May 9 at 8:28 AM
publicnow.com logoTheravance Biopharma Announces Closing of Public Offering of Its Ordinary Shares (NASDAQ:THRX)
www.publicnow.com - May 4 at 5:51 PM
publicnow.com logoTheravance Biopharma to Report First Quarter 2016 Financial Results on May 9, 2016 (NASDAQ:THRX)
www.publicnow.com - May 2 at 4:20 PM
usatoday.com logoCruise Ship Heading From Miami to Havana (NASDAQ:THRX)
www.usatoday.com - May 2 at 5:29 AM
foxnews.com logoBodies of elite climber, cameraman found in melting Himalayan glacier (NASDAQ:THRX)
www.foxnews.com - May 2 at 5:29 AM
News IconColombia deports man called Peru's most-wanted drug criminal (NASDAQ:THRX)
www.chron.com - May 1 at 7:12 PM
News Icon22 Somali Soldiers Killed in Al-Shabab Attack (NASDAQ:THRX)
www.voanews.com - May 1 at 7:12 PM
nydailynews.com logoReporters from Fox News and Huffington Post brawl at White House Correspondents’ Association dinner (NASDAQ:THRX)
www.nydailynews.com - May 1 at 7:12 PM
nydailynews.com logo'Paralyzed bride' Rachelle Chapman no longer friends with bridesmaid who pushed her into pool (NASDAQ:THRX)
www.nydailynews.com - May 1 at 7:12 PM
abcnews.go.com logoParamedic Says 'Yes' to Cop's Proposal Caught on Dash Cam (NASDAQ:THRX)
abcnews.go.com - May 1 at 7:12 PM
News IconProsecutors: After killing parents, San Jose brothers went to anime convention in Oakland (NASDAQ:THRX)
www.mercurynews.com - May 1 at 4:48 AM
nytimes.com logoPete Wilson of California Backs Ted Cruz and Warns of Donald Trump (NASDAQ:THRX)
www.nytimes.com - April 30 at 11:42 PM
News IconMicrosoft won't make cash donation to Republican convention (NASDAQ:THRX)
www.upi.com - April 30 at 6:34 PM
usatoday.com logoRacist texts prompt anti-bias training for San Francisco police (NASDAQ:THRX)
www.usatoday.com - April 30 at 6:34 PM
News IconOfficials: At least 21 dead in Baghdad car bomb (NASDAQ:THRX)
www.miamiherald.com - April 30 at 5:03 AM
News IconFake Nuns Try to Save Spanish Sex Priest (NASDAQ:THRX)
www.thedailybeast.com - April 29 at 11:56 PM
News IconTigers settle a sticky lawsuit over a fan's lemonade and a $10 bill (NASDAQ:THRX)
www.freep.com - April 29 at 11:56 PM
News IconMilitary disciplines 16 for U.S. airstrike on Doctors Without Borders hospital in Afghanistan (NASDAQ:THRX)
www.chicagotribune.com - April 29 at 6:45 PM
News IconRisoldi fraud trial put off for months (NASDAQ:THRX)
www.philly.com - April 29 at 6:45 PM
usatoday.com logo'Fargo' Cast Celebrate With Emmy Voters (NASDAQ:THRX)
www.usatoday.com - April 29 at 6:45 PM
News IconResidents of Iraq's IS-held Fallujah suffer under siege (NASDAQ:THRX)
www.mercurynews.com - April 29 at 5:18 AM
nydailynews.com logoEXCLUSIVE: Brooklyn gang member held without bail on drug charges as Instagram photos suggest murder plot (NASDAQ:THRX)
www.nydailynews.com - April 29 at 5:18 AM
publicnow.com logoTheravance Biopharma Announces Pricing of Public Offering of Its Ordinary Shares (NASDAQ:THRX)
www.publicnow.com - April 29 at 2:47 AM
News IconAPNewsBreak: Investigators look at overdose in Prince death (NASDAQ:THRX)
www.ajc.com - April 29 at 12:04 AM
foxnews.com logoAuthorities say death at Apple headquarters was suicide (NASDAQ:THRX)
www.foxnews.com - April 29 at 12:04 AM
cnn.com logoDespite Cruz pact, Indiana paper backs Kasich in bid to stop Trump (NASDAQ:THRX)
www.cnn.com - April 29 at 12:04 AM
News IconOhio State players go early, often in 1st round of NFL draft (NASDAQ:THRX)
www.chicagotribune.com - April 29 at 12:04 AM
nytimes.com logoMissing Money, a Vicious Attack and Slow Healing for a Charity’s Leader (NASDAQ:THRX)
www.nytimes.com - April 28 at 6:57 PM
News IconNext for Hastert: Prison, sex-offender program, polygraph (NASDAQ:THRX)
www.philly.com - April 28 at 6:57 PM
nbcnews.com logoE-Cigarettes Can Help Smokers Quit, U.K. Doctors Say (NASDAQ:THRX)
www.nbcnews.com - April 28 at 6:57 PM
News IconUS official visits Haiti to assess progress toward elections (NASDAQ:THRX)
www.philly.com - April 28 at 6:57 PM
News IconFBI arrests brother and other relatives of San Bernardino attacker (NASDAQ:THRX)
www.washingtonpost.com - April 28 at 6:57 PM
finance.yahoo.com logoInnoviva meets 1Q profit forecasts (NASDAQ:THRX)
finance.yahoo.com - April 28 at 5:25 PM
publicnow.com logoTheravance Biopharma Announces Proposed Public Offering of Its Ordinary Shares (NASDAQ:THRX)
www.publicnow.com - April 27 at 4:40 PM
publicnow.com logoVIBATIV(R) (Telavancin) Shows Greater In Vitro Potency Against Difficult-to-Treat Pathogens Causing Hospital-Acquired Bacterial Pneumonia, Including MRSA, Compared to Alternative Antibiotic Treatments (NASDAQ:THRX)
www.publicnow.com - April 11 at 8:20 AM
publicnow.com logoTheravance Biopharma to Present at 15th Annual Needham Health Care Conference (NASDAQ:THRX)
www.publicnow.com - April 7 at 5:02 PM
fool.com logoThe 3 Most Important Numbers When GlaxoSmithKline Reports Its Fourth-Quarter Results (NASDAQ:THRX)
www.fool.com - January 29 at 2:02 PM
finance.yahoo.com logoTheravance, Inc. Announces Name Change to Innoviva, Inc. (NASDAQ:THRX)
finance.yahoo.com - January 8 at 8:00 AM
fool.com logoWill 2016 Be GlaxoSmithKline plc's Best Year Yet? (NASDAQ:THRX)
www.fool.com - January 4 at 9:59 AM

Social

What is Innoviva's stock symbol?

Innoviva trades on the NASDAQ under the ticker symbol "THRX."

Where is Innoviva's stock going? Where will Innoviva's stock price be in 2017?

1 analysts have issued 1-year price objectives for Innoviva's shares. Their predictions range from $7.00 to $7.00. On average, they expect Innoviva's stock price to reach $7.00 in the next twelve months.

How do I buy Innoviva stock?

Shares of Innoviva can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Innoviva stock cost?

One share of Innoviva stock can currently be purchased for approximately $9.81.

Innoviva (NASDAQ:THRX) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Innoviva (NASDAQ:THRX)

Earnings History Chart

Earnings by Quarter for Innoviva (NASDAQ:THRX)

Dividend History Chart

Dividend Payments by Quarter for Innoviva (NASDAQ:THRX)

Last Updated on 2/26/2017 by MarketBeat.com Staff